Literature DB >> 10614681

Treatment of viral diseases of the cornea and external eye.

H E Kaufman1.   

Abstract

Ocular virus infections remain an important cause of corneal and external disease. Herpes simplex, the most important, is easily treated when it is confined to the epithelium. New studies indicate that herpetic stromal disease and iritis are effectively treated with a combination of corticosteroid and antiviral without additional risk. Recurrences of ocular herpetic disease can be reduced with acyclovir given orally; the benefit seems to be greatest in patients who have had at least one episode of stromal keratitis. Herpes zoster can be treated with either acyclovir or famciclovir, but to be effective, treatment must be initiated within 72 hours of onset. Early treatment reduces the risk of post-herpetic neuralgia and may reduce the risk of ocular complications. Adenovirus infection (epidemic keratoconjunctivitis) is often spread by the ophthalmologist. New medications such as cidofovir appear to be effective against the adenoviruses in non-human systems and may have some effect in man, although previously, drugs that appeared to have an effect in vitro have proven to be ineffective in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10614681     DOI: 10.1016/s1350-9462(99)00004-x

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  7 in total

1.  Evaluation of the effects of acyclovir and/or human amniotic membrane on herpes virus culture and quantitative virus inactivity by real-time polymerase chain reaction.

Authors:  Feride Aylin Kantarci; Ali Reza Faraji; Aykut Ozkul; Fikret Akata
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

Review 2.  The tug-of-war between dendritic cells and human chronic viruses.

Authors:  Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

3.  Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection.

Authors:  Herbert E Kaufman; Emily D Varnell; Bryan M Gebhardt; Hilary W Thompson; Ephraim Atwal; Helga Rübsamen-Waigmann; Gerald Kleymann
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

Review 4.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

5.  Efficacy of topical immunoglobulins against experimental adenoviral ocular infection.

Authors:  Edward C Nwanegbo; Eric G Romanowski; Y Jerold Gordon; Andrea Gambotto
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

6.  A role for chromosomal protein HMGN1 in corneal maturation.

Authors:  Yehudit Birger; Janine Davis; Takashi Furusawa; Eyal Rand; Joram Piatigorsky; Michael Bustin
Journal:  Differentiation       Date:  2006-02       Impact factor: 3.880

7.  Colloidal dispersions for the delivery of acyclovir: a comparative study.

Authors:  Rita Cortesi; Laura Ravani; Enea Menegatti; M Drechsler; Elisabetta Esposito
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.